Author

Michael Tarpley

North Carolina Central UniversityORCID 0009-0007-3712-7194Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Esraa Salim· 1 shared John E. Scott· 1 shared Kevin P. WilliamsiD· 1 shared Maria S. DixoniD· 1 shared Weifan ZhengiD· 1 shared Xiaojia Ji· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Esraa Salim

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyPLoS ONEPeer-reviewedSep 16, 2026

From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells

Esraa Salim, Xiaojia Ji, Michael Tarpley…·Kevin P. Williams

This study validates computational drug repurposing predictions for inflammatory breast cancer using experimental assays, identifying synergistic combinations that inhibit cancer cell growth and signaling pathways.

DOI 10.1371/journal.pone.0339543

humanbulk RNA-seq

𝕏 PostBluesky